Reduces excess sebum production in oil glands to prevent comedone formation
the true blockbuster of last summer was semaglutide
She is an all-in-one trainer: part trainer, part physical therapist, part dietitian and part motivational life coach
Glucagon-like peptide-1 receptor agonists in arthritis: current insights and future directions
By purchasing, you confirm that you are at least 21 years of age and that the materials will be handled in accordance with applicable laws and regulations

Based on analysis of employer experiences, vendor data, and expert interviews, PHTI outlines five key recommendations for employers: Establish clear, clinically driven eligibility pathways for GLP-1 coverage Require participation in behavior, nutrition, or lifestyle change programs as a condition of coverage Provide structured support for employees who choose to taper or discontinue GLP-1 therapy Review existing vendor capabilities before adding additional point solutions Contract with vendors to drive outcomes while examining overall program costs The report identifies three critical phases where these solutions can support employers in managing their GLP-1 coverage: Initiation: Providing targeted GLP-1 coverage using clinical criteria, behavioral or AI-based screening, narrow prescribing networks, or step-therapy pathways that include lower-cost alternatives or lifestyle change programs